Kraig Biocraft Laboratories' Recombinant Spider Silk Product Development Receives Coverage From Prestigious Textile Trade Publi
January 28 2013 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the "Company" or
"Kraig") announced today that World Textile Information Network
("WTiN") recently published an article, entitled "Commercializing
the science of spider silk", featuring the Company and its
genetically engineered spider silk technologies.
As the WTiN article states, "Kraig Biocraft Laboratories has
experienced growing success developing its recombinant spider silk
in the last two years." The article describes Kraig's product
development and includes the first published photos of the
Company's new composite spider silk fiber, "Big Red." The new
genetically engineered spider silk fiber takes its name from the
fact that it glows bright red under UV
illumination. Additional photos of what the Company hopes to
be a breakthrough material will be posted on Kraig's website.
The WTiN article is available at the following link:
http://ei.wtin.com/article/fQowSDlzdX2/2013/01/24/commercialising_the_science_of_spider_silk/.
World Textile Information Network, established more than 100
years ago and based in the UK, is the world's leading textile news
and information provider, with unrivalled textile expertise. "WTiN
Intelligence" is part of the WTiN, whose magazines include- Textile
Month International, Knitting International, Future Materials,
Nonwovens Report International, Digital Textile, Twist and
International Dyer, as well as newspapers at many of the world's
leading textile exhibitions.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com) is a fully
reporting biotechnology company that has achieved a series of
scientific breakthroughs in the area of spider silk technology with
implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "develops," "researching,"
"research," "potential," "could" or other words or phrases of
similar import. Similarly, statements in this release that describe
the Company's business strategy, outlook, objectives, plans,
intentions or goals should all be considered forward-looking
statements. All such forward-looking statements are subject to
certain risks and uncertainties that could cause actual results to
differ materially from those in forward-looking statements.
Management cautions that its ability to further its research, and
create commercially-viable products may be affected by the
competitive environment, the Company's financial condition and its
ability to raise sufficient capital to meet the financial
obligations of its business plan and to fund its continuing
operations.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security and shall not
constitute an offer, solicitation or sale of any securities in any
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of such jurisdiction.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
benhansel@yahoo.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024